SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-22-100863
Filing Date
2022-09-16
Accepted
2022-09-16 16:36:54
Documents
7
Period of Report
2022-11-07

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2225310-1_def14a.htm DEF 14A 1048034
2 GRAPHIC lg_phibrocorp-4c.jpg GRAPHIC 43603
3 GRAPHIC sg_thomasdagger-bw.jpg GRAPHIC 11708
4 GRAPHIC tm2225310d1-bc_ceo4c.jpg GRAPHIC 136716
5 GRAPHIC tm2225310d1-fc_base4c.jpg GRAPHIC 38532
6 GRAPHIC tm2225310d1-px_animalbw.jpg GRAPHIC 626244
7 GRAPHIC tm2225310d1-px_phibrobw.jpg GRAPHIC 1094794
  Complete submission text file 0001104659-22-100863.txt   3643424
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

IRS No.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-36410 | Film No.: 221248521
SIC: 2834 Pharmaceutical Preparations